Null mutations of GSTM1 and GSTT1 phase II enzymes have been shown to halt enzyme activity resulting in greater susceptibility to environmental toxins and carcinogens related to an increased risk of cancer [40,49]. The gene discussed is GSTM1; the disease is cancer.